相关实验视频

Updated: May 7, 2026

Isolation of Cortical Microglia with Preserved Immunophenotype and Functionality From Murine Neonates

Isolation of Cortical Microglia with Preserved Immunophenotype and Functionality From Murine Neonates

Published on: January 30, 2014

由DNase II缺乏引起的微质双链DNA积累驱动神经炎症和神经退行

Ling-Jie Li^1,2, Shi-Yu Liang^1,2, Xiao-Ying Sun¹

¹State Key Laboratory of Biopharmaceutical Preparation and Delivery, Institute of Process Engineering, Chinese Academy of Sciences, Haidian District, Beijing, 100190, China.

Journal of neuroinflammation

|January 20, 2025

概括

微体脱氧核糖酶2 (DNase II) 缺乏会通过激活炎症通路和促进DNA积累,加剧阿尔茨海默病的病理. 降低微质中的DNase II水平可能为神经退行性疾病提供治疗点.

科学领域:

神经科学是一个神经科学.
免疫学免疫学免疫学
遗传学是一个遗传学.

背景情况:

脱氧核糖核酶2 (DNase II) 清除细胞质双链DNA (dsDNA),其缺乏与神经退行有关.
微质DNase II在神经炎症和阿尔茨海默病 (AD) 中的作用尚不清楚.
以前的工作将神经元DNase II缺陷与tau病理联系起来.

研究的目的:

调查微质DNase II在阿尔茨海默氏症病原发生中的作用.
探索微质DNase II缺乏对神经炎症和AD相关病理的影响.

主要方法:

在3xTg-AD小鼠中评估微质DNase II水平.
在使用行为测试的DNase II缺陷小鼠中评估认知功能.
分析了微质形态,cGAS-STING和IFN-I通路激活,神经炎症,突触损失,粉样蛋白病理和病.

主要成果:

在3xTg-AD小鼠中,微质DNase II水平降低.
微质中的DNase II缺乏激活了cGAS-STING和IFN-I通路,增加了神经炎症.
这种缺乏导致突触损失,粉样蛋白-β和病理的升高,以及认知能力下降.

结论:

微质DNase II缺乏导致神经炎症和AD病理通过细胞质dSDNA积累.
这些发现表明DNase II是AD等神经退行性疾病的潜在治疗点.

关键词:

阿尔茨海默病 (AD) 是一种疾病.DNase II 的第二部分.双链DNA (dsDNA) 是一种双链DNA.神经炎症是一种神经炎症.第一种类型的干扰子通路.在cGAS-STING路径中.

更多相关视频

Mass Histology to Quantify Neurodegeneration in Drosophila

Mass Histology to Quantify Neurodegeneration in Drosophila

Published on: December 15, 2016

Immunofluorescence Staining Using IBA1 and TMEM119 for Microglial Density, Morphology and Peripheral Myeloid Cell Infiltration Analysis in Mouse Brain

Immunofluorescence Staining Using IBA1 and TMEM119 for Microglial Density, Morphology and Peripheral Myeloid Cell Infiltration Analysis in Mouse Brain

Published on: October 27, 2019

相关概念视频

Encephalitis ll: Pathophysiology

Encephalitis ll: Pathophysiology

Encephalitis is inflammation of the brain parenchyma caused by direct viral invasion or immune-mediated mechanisms triggered by infections or tumors. Both processes lead to neuronal injury, disrupted neurotransmission, and diverse neurological symptoms, often with overlapping clinical and pathological features.Autoimmune EncephalitisIn autoimmune encephalitis, antibodies target neuronal antigens on cell surfaces, synapses, or within neurons. A key example is anti-NMDAR encephalitis, which can...

Alzheimer Disease ll: Pathophysiology

Alzheimer Disease ll: Pathophysiology

Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and microglia. Abnormal...

Parkinson Disease ll: Pathophysiology

Parkinson Disease ll: Pathophysiology

Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...